HR3631-119

Introduced

To criminalize fraudulent statements made with respect to clinical vaccine trials.

119th Congress Introduced May 29, 2025

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

This bill, To criminalize fraudulent statements made with respect to clinical vaccine trials., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Criminal Justice, Technology.

Who Benefits and How

health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.

Who Bears the Burden and How

federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.

Key Provisions

  • Section H03F93AAA47AF4C0C9C070E7F203947BD: 1. Short title This Act may be cited as the Vaccines in Trial and Liability Act of 2025 or the VITAL Act of 2025.
  • Section HFD5541E16B304423BBD06E032B2D05B3: 2. Medical research company or sponsor Chapter 47 of title 18, United States Code, is amended by adding at the end the following: Whoever, being a medical...
  • Section H3888107BFFE94606BF8B72A33B6C2DD3: 1041. Clinical vaccine trial fraud Whoever, being a medical research company or sponsor, makes a fraudulent statement to, or conceals from, any department or...
  • Section H0470AD21684447DF99D0A0FB87CECB03: 3. Scope of authorization Section 564(c) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb–3(c)) is amended— in paragraph (4), by striking and; by...
  • Section H28CE5861DA28490D81224D586C97046C: 4. Revision and revocation Section 564(g)(2) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb–3(g)(2)) is amended— in subparagraph (B), by...

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

This bill, To criminalize fraudulent statements made with respect to clinical vaccine trials., changes federal law or congressional policy affecting health care providers and patients.

Key Policy Areas

Healthcare, Criminal Justice, Technology

Primary Purpose

This bill, To criminalize fraudulent statements made with respect to clinical vaccine trials., changes federal law or congressional policy affecting health care providers and patients.

Policy Domains

Healthcare Criminal Justice Technology

Whole bill

Identified Gains
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
health care providers and patients: ,
Identified Costs
  • federal implementing agencies
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
federal implementing agencies: ,
health care providers and patients: ,

Legislative Progress

Introduced
Introduced Committee Passed
May 29, 2025

Mr. Green of Tennessee introduced the following bill; which was …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Criminal Justice Technology
Actor Mappings
"secretary_of_health_and_human_services"
→ Secretary of Health and Human Services

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology